Skip to main content
bioAffinity Technologies, Inc. logo

bioAffinity Technologies, Inc. - Investor Relations & Filings

Listed IPO Sep 2022
Ticker · BIAF ISIN · CA09064N1033 US Professional, scientific and technical activities
Open in API
Filings indexed 342 across all filing types
Latest filing 2025-07-07 Regulatory Filings
Country US United States of America
Listing US BIAF · 1 venue

About bioAffinity Technologies, Inc.

https://bioaffinitytech.com/

bioAffinity Technologies, Inc. is a company focused on developing noninvasive diagnostics and targeted therapeutics for cancer. Its first commercialized product, CyPath® Lung, is a non-invasive laboratory developed test for the early detection of lung cancer. The test is designed for individuals at high risk who have suspicious but indeterminate findings on a low-dose computed tomography (LDCT) scan. CyPath® Lung analyzes patient sputum samples using an automated flow cytometry platform and machine learning to identify cell populations indicative of cancer. This approach aims to improve diagnostic accuracy, reduce unnecessary invasive procedures, and lower associated healthcare costs. The company's core technology is based on a proprietary porphyrin platform that preferentially targets cancer cells, with ongoing research to expand its application to other diagnostics and therapeutics.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings
2025-07-07 English
POS AM
Regulatory Filings Classification · 100% confidence The document is a Post-Effective Amendment No. 1 to a Form S-1 Registration Statement filed with the SEC under the Securities Act of 1933. It discusses registration of securities for resale, private placements, warrants, and related securities offerings. The document is a regulatory filing related to securities registration and amendments to previously filed registration statements. It is not an annual report, earnings release, or any other financial report type. It is a formal SEC filing concerning securities registration and amendments, which fits the category of Regulatory Filings (RNS).
2025-06-27 English
POS AM
Regulatory Filings Classification · 100% confidence The document is a Post-Effective Amendment No. 3 to a Form S-1 Registration Statement filed with the SEC. It is related to the registration of securities under the Securities Act of 1933, specifically concerning the issuance of common stock upon exercise of warrants from an initial public offering. The document includes detailed information about the offering, securities, risk factors, use of proceeds, management discussion and analysis, and other disclosures typical of a registration statement amendment. It is not an annual report, earnings release, or any other financial report but a regulatory filing related to securities registration and offering. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other categories.
2025-06-27 English
ARS
Annual Report
2025-06-02 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It is labeled as "Definitive Additional Materials" related to a proxy statement. Proxy statements are materials sent to shareholders to provide information and request votes for meetings. The document does not contain financial statements or earnings data, nor is it an announcement of a report publication. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is short and it is clearly a proxy statement filing, confirming the classification.
2025-06-02 English
DEF 14A
Proxy Solicitation & Information Statement
2025-06-02 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.